Peter D. Kies
2014
In 2014, Peter D. Kies earned a total compensation of $1.1M as Chief Financial Officer at Inovio Pharmaceuticals, a 129% increase compared to previous year.
Compensation breakdown
| Bonus | $127,493 |
|---|---|
| Option Awards | $659,875 |
| Salary | $347,941 |
| Other | $6,405 |
| Total | $1,141,714 |
Kies received $659.9K in option awards, accounting for 58% of the total pay in 2014.
Kies also received $127.5K in bonus, $347.9K in salary and $6.4K in other compensation.
Rankings
In 2014, Peter D. Kies' compensation ranked 6,996th out of 13,032 executives tracked by ExecPay. In other words, Kies earned more than 46.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,996 out of 13,032 | 46th |
Division Manufacturing | 2,571 out of 4,965 | 48th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 323 out of 731 | 56th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 176 out of 441 | 60th |
Industry Surgical and Medical Instruments and Apparatus | 99 out of 270 | 63rd |
Source: SEC filing on March 29, 2017.
Kies' colleagues
We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2014.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019